Northern Trust’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-42,193
| Closed | -$29.5K | – | 4629 |
|
|
2023
Q1 | $29.5K | Sell |
42,193
-39
| -0.1% | -$27 | ﹤0.01% | 4376 |
|
|
2022
Q4 | $38K | Sell |
42,232
-37
| -0.1% | -$33 | ﹤0.01% | 4349 |
|
|
2022
Q3 | $254K | Buy |
42,269
+4,334
| +11% | +$26K | ﹤0.01% | 3756 |
|
|
2022
Q2 | $157K | Sell |
37,935
-823
| -2% | -$3.41K | ﹤0.01% | 4011 |
|
|
2022
Q1 | $148K | Sell |
38,758
-528
| -1% | -$2.02K | ﹤0.01% | 4231 |
|
|
2021
Q4 | $177K | Buy |
39,286
+7,088
| +22% | +$31.9K | ﹤0.01% | 4240 |
|
|
2021
Q3 | $150K | Buy |
32,198
+7,898
| +33% | +$36.8K | ﹤0.01% | 4280 |
|
|
2021
Q2 | $171K | Sell |
24,300
-84,436
| -78% | -$594K | ﹤0.01% | 4212 |
|
|
2021
Q1 | $642K | Sell |
108,736
-14,004
| -11% | -$82.7K | ﹤0.01% | 3742 |
|
|
2020
Q4 | $566K | Sell |
122,740
-834
| -0.7% | -$3.85K | ﹤0.01% | 3692 |
|
|
2020
Q3 | $481K | Sell |
123,574
-3,432
| -3% | -$13.4K | ﹤0.01% | 3619 |
|
|
2020
Q2 | $3.65M | Buy |
127,006
+67,852
| +115% | +$1.95M | ﹤0.01% | 2708 |
|
|
2020
Q1 | $1.27M | Buy |
59,154
+6,008
| +11% | +$129K | ﹤0.01% | 3097 |
|
|
2019
Q4 | $1.05M | Buy |
53,146
+46,185
| +663% | +$909K | ﹤0.01% | 3379 |
|
|
2019
Q3 | $104K | Buy |
+6,961
| New | +$104K | ﹤0.01% | 3918 |
|